Trials / Sponsors / InFlectis BioScience
InFlectis BioScience
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Treatment Combining Riluzole and IFB-088 in Bulbar Amyotrophic Lateral Sclerosis (TRIALS Protocol) Amyotrophic Lateral Sclerosis, ALS | Phase 2 | 2022-12-02 |
| Completed | A Combined SAD and MAD Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of IFB-088 Healthy Volunteers | Phase 1 | 2018-06-21 |